Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.

ABSTRACT:

SUBMITTER: Nishimura JI 

PROVIDER: S-EPMC9152970 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature